Strategic Expansion: Manipal HealthMap Completes Full Acquisition of Medcis PathLabs

▴ Manipal HealthMap
Manipal HealthMap highlighted that the acquisition will expand its footprint by adding 23 new centres to its Manipal TRUtest network. This network, post-acquisition, will comprise over 100 centers, serving a vast customer base exceeding 50 lahks across 16 states.

Bengaluru-based diagnostic services provider, Manipal HealthMap, has recently concluded the acquisition of a 100% stake in Medcis PathLabs, a prominent player based in Hyderabad. This strategic acquisition comes on the heels of Manipal HealthMap's earlier investment in April 2022, where they acquired an 84% stake in Medcis PathLabs for a substantial sum of Rs 100 crore in an all-cash transaction.

This recent development signifies Manipal HealthMap's commitment to solidify its position as the leading integrated diagnostics services brand within the Manipal Group. The acquisition of the remaining 16% stake in Medcis PathLabs marks a pivotal step towards this goal. Dr (Capt) Sandeep Sharma, the CEO of Manipal HealthMap, expressed that this acquisition aligns with their broader plans and vision for growth in the diagnostics sector.

Dr Bharat Kumar Anagani, the CEO of Medcis PathLabs, will continue to play a crucial role in overseeing the seamless integration of Medcis PathLabs into the Manipal HealthMap ecosystem. This collaborative effort aims to bring about synergies that enhance the overall efficiency and effectiveness of diagnostic services.

The combined entity, post-acquisition, is set to have a consolidated back-end operation for its laboratories located in key cities like Pune, Delhi-NCR, Bengaluru, Kolhapur, and Nagpur. This strategic consolidation is anticipated to streamline operations, leverage shared resources, and optimize service delivery to a larger audience.

Medcis PathLabs, known for its high-quality diagnostics services, operates a central laboratory in Hyderabad with NABL accreditation. The specialities of this central lab include molecular, cytogenetics, histopathology, and microbiology. Additionally, the various labs under Medcis PathLabs offer a spectrum of services, covering biochemistry, haematology, and immunology tests.

Manipal HealthMap highlighted that the acquisition will expand its footprint by adding 23 new centers to its Manipal TRUtest network. This network, post-acquisition, will comprise over 100 centers, serving a vast customer base exceeding 50 lahks across 16 states. The geographical diversification and increased service points are expected to enhance accessibility and convenience for patients seeking diagnostic services.

Manipal HealthMap, with its integrated diagnostic centres, caters to a wide range of diagnostic needs, including various tests, scans, blood tests, X-rays, and MRI scans. The services extend across diverse segments, including business-to-government (B2G), business-to-business (B2B), business-to-consumer (B2C), and corporate segments.

This strategic move underlines the dynamism and growth potential in the healthcare industry, where consolidation and integration are becoming key strategies to offer comprehensive and efficient services to a broader audience. As Manipal HealthMap continues to evolve and expand its network, the focus remains on delivering quality diagnostic services that contribute to the well-being of individuals and communities across the country. Stay tuned for more updates on this transformative journey in healthcare

Tags : #manipalhealthmap #medcispathlabs #acqusition #expansion #manipalgroups #medicircle

About the Author

Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...


Trending Now

DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024
IT Minister Sridhar Babu to grace the 10th National Facilities Managers Summit-2024, to be held in the cityMay 15, 2024
Alarming Study Reveals Cancer-Causing Chemicals in Car InteriorsMay 15, 2024
India's Thalassemia Challenge: The Importance of Early Screening and TreatmentMay 15, 2024
The Dangers of Ultra-Processed Foods: A 30-Year Study Raises AlarmsMay 15, 2024
Unique Genetic Risk Factors for Breast Cancer Found in African Ancestry StudyMay 15, 2024
AsiaMedic partners with Sunway to establish new diagnostic imaging centreMay 14, 2024